Rahul Sharma, MD
Interventional Cardiology · Peoria, AZNPI 1063675288
Payments from drug & device makers
Across 511 payments — averaging $381.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$139K
- Edwards Lifesciences$27K
- Medtronic$9K
- Cathworks, Inc.$5K
- Boston Scientific$4K
- Cardiva Medical, Inc.$4K
- plus $7K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 257 | $139,305 |
| Edwards Lifesciences | 62 | $26,744 |
| Medtronic(2 entities) | 42 | $8,848 |
| Cathworks, Inc. | 1 | $5,250 |
| Boston Scientific | 42 | $4,189 |
| Cardiva Medical, Inc. | 6 | $4,106 |
| Ancora Heart, Inc. | 8 | $2,325 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 23 | $1,160 |
| Abiomed | 22 | $1,116 |
| Philips North America LLC | 5 | $457 |
| Cardiovascular Systems Inc. | 3 | $350 |
| W. L. Gore & Associates, Inc. | 1 | $172 |
| Novartis | 6 | $129 |
| Biosense Webster, Inc. | 2 | $114 |
| Heartflow, Inc. | 1 | $108 |
| E.r. Squibb & Sons, L.L.C. | 5 | $93 |
| Sanofi | 1 | $70 |
| Jenavalve Technology, Inc. | 1 | $70 |
| Chiesi USA, Inc. | 3 | $57 |
| Baylis Medical Company Inc | 1 | $50 |
| AstraZeneca | 3 | $46 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| Bayer | 2 | $40 |
| Pfizer | 2 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $33 |
| Atricure, Inc. | 2 | $31 |
| Johnson & Johnson | 2 | $31 |
| Boehringer Ingelheim | 1 | $29 |
| Kestra Medical Technology Services, Inc. | 1 | $28 |
| Merck | 1 | $26 |
| Amgen | 1 | $19 |
| Novo Nordisk | 1 | $15 |
How this compares
$195,087 in reported general payments places this provider in the 85th percentile of 223 interventional cardiology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Peoria
- Azimuddin KhawajaPeoria$199K
- Michael AmponsahPeoria$46K
- Paul SorajjaPhoenix$8.8M
- Thomas WaggonerTucson$4.1M
- Hursh NaikAvondale$2.2M
- Nabil DibGilbert$2.2M
- Timothy ByrnePhoenix$2.1M
- Ashish PershadChandler$1.4M
- Mohamad LazkaniPhoenix$1.1M
- Parminder SinghPhoenix$854K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.